Increased expression of lncRNA ITGB2-AS1 was observed in cisplatin-resistant NSCLC cells and NSCLC patients, which was positively correlated negative repression of ferroptosis [176](Fig. 5 and Table 2). This evidence concerns the gene ITGB2 and non-small cell lung carcinoma.